Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Apr;4(2):127-34.
doi: 10.2174/156720507780362100.

Adiposity and Alzheimer's disease

Jose A Luchsinger  1 , Richard Mayeux
Affiliations
Review

Adiposity and Alzheimer's disease

Jose A Luchsinger et al. Curr Alzheimer Res. 2007 Apr.

Abstract

The objective of this manuscript is to provide a comprehensive review of the relation between adiposity and Alzheimer's disease (AD), its potential mechanisms, and issues in its study. Adiposity represents the body fat tissue content. When the degree of adiposity increases it can be defined as being overweight or obese by measures such as the body mass index. Being overweight or obese is a cause of hyperinsulinemia and diabetes, both of which are risk factors for AD. However, the epidemiologic evidence linking the degree of adiposity and AD is conflicting. Traditional adiposity measures such as body mass index have decreased validity in the elderly. Increased adiposity in early or middle adult life leads to hyperinsulinemia which may lead to diabetes later in life. Thus, the timing of ascertainment of adiposity and its related factors is critical in understanding how it might fit into the pathogenesis of AD. We believe that the most plausible mechanism relating adiposity to AD is hyperinsulinemia, but it is unclear whether specific products of adipose tissue also have a role. Being overweight or obese is increasing in children and adults, thus understanding the association between adiposity and AD has important public health implications.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Correlation between the construct of adiposity, body mass index (and the NHLBI classification), and waist circumference.
Figure 2
Figure 2
Natural history of the continuum of adiposity, insulin resistance, hyperinsulinemia, glucose intolerance and diabetes. Increased adiposity causes insulin resistance and hyperinsulinemia. Insulin levels may decrease over time due to pancreatic failure, and glucose intolerance and diabetes ensue. Hypothetically, high insulin levels and then diabetes related processes could increase brain amyloid beta deposition leading to Alzheimer’s disease. It is unclear when this process starts, but it could begin in early adulthood or even childhood. As depicted in the figure, these factors change with time, and the timing of their ascertainment may affect findings in epidemiological and clinical studies.
Figure 3
Figure 3
Hazard ratios relating quartiles (Q) of body mass index (BMI) to Alzheimer’s disease in persons < 76 years old and persons ≥ 76 years old, adjusting for age, sex, years of education, ethnic group, and APOEɛ4. Only the HR for the 3rd and 4th quartiles in persons < 76 years were statistically significant. The Washington Heights Inwood Columbia Aging Project, 1992–2003.
Figure 4
Figure 4
Hazard ratios [16] relating quartiles (Q) of waist circumference (WC) to Alzheimer’s disease in persons < 76 years old and persons ≥ 76 years old, adjusting for age, sex, years of education, ethnic group, and APOEɛ4. The HR for the 4th Q of WC and the p for trend in persons < 76 years were statistically significant. The Washington Heights Inwood Columbia Aging Project, 1992–2003.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ritchie K, Lovestone S. The dementias. Lancet. 2002;360:1759–66. - PubMed
    1. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998;88:1337–42. - PMC - PubMed
    1. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA. 1989;262:2551–6.. - PubMed
    1. Selkoe DJ. The origins of Alzheimer disease: a is for amyloid. JAMA. 2000;283:1615–7. - PubMed
    1. Selkoe DJ. Alzheimer's disease: genotypes, phenotypes, and treatments. Science. 1997;275:630–1.. - PubMed

Publication types